KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $16.5 billion.

  • Bristol Myers Squibb's Cash & Current Investments rose 10387.94% to $16.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $16.5 billion, marking a year-over-year increase of 10387.94%. This contributed to the annual value of $10.9 billion for FY2024, which is 1157.17% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Cash & Current Investments stood at $16.5 billion for Q3 2025, which was up 10387.94% from $13.6 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Cash & Current Investments peaked at $17.0 billion during Q4 2021, and registered a low of $6.7 billion during Q2 2024.
  • Over the past 5 years, Bristol Myers Squibb's median Cash & Current Investments value was $11.8 billion (recorded in 2025), while the average stood at $11.6 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Cash & Current Investments crashed by 4546.15% in 2022, and later soared by 10446.42% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Cash & Current Investments (Quarter) stood at $17.0 billion in 2021, then tumbled by 45.46% to $9.3 billion in 2022, then soared by 32.71% to $12.3 billion in 2023, then decreased by 11.57% to $10.9 billion in 2024, then soared by 51.97% to $16.5 billion in 2025.
  • Its Cash & Current Investments stands at $16.5 billion for Q3 2025, versus $13.6 billion for Q2 2025 and $11.8 billion for Q1 2025.